WB4-24, a non-peptide GLP-1 receptor agonist, demonstrated dose-dependent attenuation in mouse models of acute and chronic inflammatory nociception via the release of -endorphins from spinal microglia [17]
And I even found a recent randomized controlled trial in men taking dulaglutide specifically looking at sexual performance
The combination of fat pad atrophy, possible peripheral neuropathy, and shoes that no longer fit properly can lead to wounds that don't heal
7 Pharmacists should be diligent in staying up to date with emerging benefits of GLP-1 RAs, especially in new indications such as PD, and follow releases of new clinical data that more confidently highlight the role of GLP-1 RAs in PD
The nutrition industry has developed various GLP-1 companion products to help users alleviate some of these well-known issues
How treatment duration affects total spending Treatment duration determines cost escalation patterns